Intellectual Property India Publishes Patent Application for '2,3-Didihydro-5-((8-Hydroxyquinolin-5-Yl)Methyl)-2-Thioxopyrimidin-4(1h)-Ones And Process For Preparation Thereof' Filed by Prashant R. Murumkar; Rasana Yadav; Omkumar A. Prajapati; and The Maharaja Sayajirao University Of Baroda

MUMBAI, India, April 17 -- Intellectual Property India has published a patent application (202621023560 A) filed by Prashant R. Murumkar; Rasana Yadav; Omkumar A. Prajapati; and The Maharaja Sayajirao University Of Baroda, Vadodara, Gujarat, on Feb. 27, for '2,3-didihydro-5-((8-hydroxyquinolin-5-yl)methyl)-2-thioxopyrimidin-4(1h)-ones and process for preparation thereof.'

Inventor(s) include Prashant R. Murumkar; Rasana Yadav; and Omkumar A. Prajapati.

The application for the patent was published on April 17, under issue no. 16/2026.

According to the abstract released by the Intellectual Property India: "2,3-Dihydro-5-((8-hydroxyquinolin-5-yl)methyl)-2-thioxopyrimidin-4(1H)-ones and process for preparation thereof The present invention relates to 2,3-dihydro-5-((8-hydroxyquinolin-5-yl)methyl)-2-thioxopyrimidin-4(1H)-ones and process for preparation thereof. The present invention specifically relates to a compound 2-(4-fluorobenzylthio)-5-((8-hydroxyquinolin-5-yl)methyl)-6-phenylpyrimidin-4(3H)-one. The present invention further relates to the use of compound 2-(4-fluorobenzylthio)-5-((8-hydroxyquinolin-5-yl)methyl)-6-phenylpyrimidin-4(3H)-one as MAO-B inhibitor."

Disclaimer: Curated by HT Syndication.